Friday, July 10, 2026

Drug profile · INN

megestrol

megestrol is a progesterone receptor agonist.

NMPA: clinical trials
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — megestrol
Class
Route
Patents
0
Programs
6
Data quality
0.70

Quick answer

megestrol is a progesterone receptor agonist.

Key facts

INN megestrol
Mechanism Progesterone receptor agonist
Target Progesterone receptor

Mechanism of action

Progesterone receptor agonist

Primary target: Progesterone receptor

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. MK-5684-015 Phase 3 · MSD Merck Sharp · Breast cancer, Ovarian cancer, Endometrial cancer
  2. Megestrol(Yining) Phase 3 · First People's Hospital · Stage III Esophageal Squamous Cell Carcinoma
  3. Nano-crystalline Megestrol Acetate Oral Suspension Phase 3 · Chinese Academy of · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
  4. megestrol acetate oral suspension + serplulimab + SOX Phase 2 · First People's Hospital · Stage III Gastric Cancer
  5. Megestrol acetate Unknown · Actuate Therapeutics · HIV Infections
  6. megestrol Unknown · Ultragenyx UK · Acquired Immunodeficiency Syndrome

Related & competitor drugs

  1. desogestrel Progesterone receptor agonist
  2. medroxyprogesterone acetate Progesterone receptor agonist
  3. megestrol acetate Progesterone receptor agonist
  4. norethindrone Progesterone receptor agonist
  5. norethindrone acetate Progesterone receptor agonist
  6. progesterone Progesterone receptor agonist

Frequently asked questions

What is megestrol?

megestrol is a progesterone receptor agonist.